Sponsor:
Hoffmann-La Roche
Code:
NCT05908786
Conditions
Carcinoma, Hepatocellular
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Atezolizumab
Bevacizumab
Tiragolumab
Tobemstomig
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations